The prize given by MERCK-SHARP-DHOME ARGENTINA and THE MINISTRY OF SCIENCE, TECHNOLOGY AND INNOVATION rewards the most talented Start-ups and health technology based companies from Argentina with potential of global …
This is a single-center, open-label, dose-escalating phase I clinical trial in healthy volunteers 18 to 60 years old. This clinical trial is designed to assess the safety, and pharmacokinetics of …
We are excited to take part of the biggest International Pharma Industry event. Immunalgia Therapeutics, an ambitious and proactive Argentinean Company, is ready to present its innovative technologies for the …
This article in Spanish “Dolor Crónico: Una voz para los más débiles” was published on 05/09/2022 by a national newspaper (Perfil Eds) by two of our board members; Dr. Pablo …
